Biol Reprod
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pitzel, L.
Right arrow Articles by Wuttke, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pitzel, L.
Right arrow Articles by Wuttke, W.
Agricola
Right arrow Articles by Pitzel, L.
Right arrow Articles by Wuttke, W.
Biology of Reproduction 62, 1121-1127 (2000)
© 2000 Society for the Study of Reproduction, Inc.


Articles

Secretion and Gene Expression of Metalloproteinases and Gene Expression of Their Inhibitors in Porcine Corpora Lutea at Different Stages of the Luteal Phase1

Lutz Pitzel2,a, Sabine Lüdemanna, and Wolfgang Wuttkea

a Clinical and Experimental Endocrinology, Department of Obstetrics and Gynecology, University of Göttingen, 37075 Göttingen, Germany


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
We hypothesize that spontaneous regression of corpora lutea (CL) involves short-lasting restructure of luteal tissue with an activation of matrix metalloproteinases (MMPs) and their respective inhibitors (tissue inhibitors of metalloproteinase, TIMPs). This was tested by determining the gene expression of MMP-1, MMP-2, and MMP-9 and respective TIMP-1 and TIMP-2 in luteal tissue from sows at the early, midluteal, and late luteal phase (Days 6–8, Days 9–11, and Days 13–15 of estrous cycle). Gene expression of the three MMPs was low in early, slightly higher in midluteal, and significantly elevated (P < 0.05) in regressing CL. An inverse pattern was found for gene expression of TIMP-1 and TIMP-2. Under culture conditions, the release of MMPs was determined from steroidogenic large luteal cells (LLC). LLC harvested from regressing CL released significantly (P < 0.05) more active MMPs than cells obtained from CL at the early luteal phase. As luteolysis can be induced by prostaglandin F2{alpha} (PGF2{alpha}) and tumor necrosis factor {alpha} (TNF), we studied their effects on LLC under culture conditions. Treatment of cells with PGF2{alpha} or TNF (10-7 M or 3 x 10-9 M, respectively) induced a significantly higher release of MMPs, and gene expression was also significantly stimulated in comparison to that in untreated LLC. The gene expression of TIMPs remained unaffected by either treatment. It is concluded that at the beginning of luteolysis, MMPs are expressed and released in high amounts and that this is essential for the structural regression of the CL.


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
The formation and the regression of corpora lutea (CL) are essential for normal ovarian cyclicity and thereby for normal reproduction. Ovulation and formation of CL are characterized by excessive remodeling of tissue. It is well known that remodeling of tissue during inflammatory processes is controlled by activated metalloproteinases and their inhibitors [1]. In 1980, Espey [2] suggested that the process of ovulation is regulated similarly to processes involved in inflammation, and later others and ourselves demonstrated activation of metalloproteinases during ovulation [36]. The morphological destruction of CL, i.e., structural luteolysis, is also coupled with massive tissue remodeling; and it is most likely that metalloproteinases and their inhibitors are also involved in this process [3]. During ovulation, three types of matrix metalloproteinases (MMPs) are activated: the MMP-1 (molecular mass 52–57 kDa, collagenase type I, interstitial collagenase), the MMP-2 (molecular mass 72 kDa, collagenase type IV, gelatinase A), and the MMP-9 (molecular mass 92 kDa, which is also a collagenase type IV, gelatinase B) [7]. All three MMPs are produced as inactive zymogens and require activation before attaining catalytic capacities to cleave native collagen and gelatin fragments [1, 7]. Collagenolytic activities of the MMPs are locally regulated by specific inhibitors, called tissue inhibitor of metalloproteinase (TIMP). The glycoprotein TIMP-1 (28.5 kDa) inhibits activated MMP-1 and MMP-9, whereas the protein TIMP-2 (21 kDa) is capable of binding to both the latent and activated forms of MMP-2 and MMP-9. It is generally believed that the balance between the MMPs and their inhibitors is essential for the control of degradation of extracellular collagen matrices [1, 7, 8]. The presence of TIMP-1 mRNA in bovine [9], ovine [10], porcine [11], and rat luteal tissue [12, 13] is suggestive that MMP-1 is also produced by luteal cells. Recently, gene expression or release of MMP-1, MMP-2, and MMP-9 has been demonstrated in bovine, human, and rat luteal cells [3, 14, 15], while TIMP-2 as local inhibitor of MMP-2 and MMP-9 is present in luteal tissue of sheep [16], humans [15], and cows [17]. The MMPs are secretory proteins, and with use of their gelatinolytic properties they can be measured by the method of zymography [3, 6, 18].

Little is known about the MMP and TIMP gene expression during the course of the luteal phase in the pig. Therefore, we studied expression of their genes in CL obtained during the early, mid, and late luteal phases.

It is well known that steroidogenic cells of the CL consist of two different populations: the so-called small (SLC) and large luteal cells (LLC) [19, 20]. The LLC are luteinized granulosa cells, and they can be easily separated from other cell types by gravity methods [21, 22].

Luteolysis in the pig requires an intact uterus, and it is established that endometrial prostaglandin F2{alpha} (PGF2{alpha}) initiates luteolysis [23]. Furthermore, it was shown that PGF2{alpha}-induced luteolysis is accompanied by invasion of macrophages into the CL [24]. Macrophages are known to produce tumor necrosis factor {alpha} (TNF) [25], and we showed recently that TNF makes the CL extremely susceptive to the luteolytic action of PGF2{alpha} [26]. Therefore, we also studied the effects of TNF and PGF2{alpha} on MMP and TIMP gene expression in LLC. In addition, the secretion of the three MMPs into the culture media was determined.

In summary, this study was initiated to test whether structural luteolysis of CL may involve MMPs and their TIMPs and whether regulatory effects of luteolysins PGF2{alpha} and TNF on gene expression and release of MMPs can be demonstrated.


    MATERIALS AND METHODS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
German Landrace pigs were kept at our university animal farm facilities, and their standing estrous reflex was studied daily. The first day of standing heat was designated as Day 0 of the estrous cycle. Groups of animals were killed at our university slaughter facilities at Days 6–8, 9–11, and 13–15 of the estrous cycle. The ovaries were brought to the laboratory in chilled PBS containing penicillin (100 U/ml) and streptomycin (100 µg/ml). The CL were cut in halves, and one half of each CL was dissected, sliced and minced, and finally dissociated at 37°C in Hepes-buffered (15 mM) Ham's F-12 (Sigma, Munich, Germany) containing 0.2% BSA and 0.2% collagenase (Worthington, Freehold, NJ) as described earlier [27]. In brief, dispersed luteal cells were separated from undigested tissue by filtration through a nylon gauze (70 µm) followed by washing twice with fresh Ham's F-12. Thereafter, the cell suspension was brought onto a 60% Percoll (Pharmacia and Upjohn, Kalamazoo, MI) solution to eliminate red blood cells. After centrifugation at 400 x g for 10 min, the enriched luteal cell fraction was washed and aspirated to 5 ml Ham's F-12. Possible aggregates in the cell suspension were again removed by filtration through a nylon gauze. Thereafter, the suspension was layered on a discontinuous Percoll gradient prepared from 40%, 20%, 15%, 10%, and 5% Percoll fractions in 0.9% NaCl in a 50-ml Falcon (Los Angeles, CA) tube. After sedimentation at 1 x g for 30 min, LLC were harvested from the 40% Percoll fraction. After washing with Ham's F-12, the purity and viability of each fraction were assessed by phase-contrast microscopy with an ocular micrometer and by trypan blue dye test. LLC had diameters > 20 µm, and the LLC fraction was contaminated with less than 8% of SLC (diameter < 20 µm). LLC were transferred into culture medium 199 (Sigma) containing 14 mM Hepes, 17 mM NaHCO3, and 0.2% BSA that was supplemented with 15% fetal calf serum (FCS), antibiotics (100 µg/ml streptomycin, 50 µg/ml gentamycin), insulin (15.6 U/L), and dexamethasone (100 nM) such that 2 ml culture medium contained 2 x 105 viable cells. They were cultured in 6-well dishes (Costar; Tecnomara, Fernwald, Germany) under standardized conditions (37°C, 5% CO2, 95% air) for a total time of 72 h. Culture medium was changed after the first 24 h. In the renewed culture medium, FCS was reduced to 5%. In each of the three experiments, the LLC (6 wells per treatment) either were left untreated or were treated with PGF2{alpha} (10-7 M final dilution) or with TNF (3 x 10-9 M final dilution). After an additional incubation period of 48 h, the media of LLC cultures were collected and stored at -20°C for measuring MMP and progesterone secretion. Cultured LLC were subsequently harvested and used for RNA extraction.

Reverse Transcription-Polymerase Chain Reaction(RT-PCR) and Cloning and Sequencing of PorcineMMP-1, MMP-2, MMP-9, TIMP-1, and TIMP-2 of LutealTissue and LLC

The RNA of intact luteal tissue and of cultured LLC (of at least three independent experiments with 6 wells per treatment) was isolated by the guanidinium thiocyanate-phenol-chloroform extraction method [28]. When cell cultures were finished, the media were removed and cells were lysed in 0.6 ml lysis buffer (4 M guanidinium thiocyanate, 25 mM sodium tricitrate, pH 7.0; 0.5% sodium-laurylsarcosine; 0.1 ml mercaptoethanol) and sonicated for 15 sec. This solution was transferred into a 1.5-ml reaction tube; and 60 µl 2 M sodium acetate, 0.6 ml phenol solution (pH 4.0), and 100 µl chloroform-isoamyl alcohol (24:1) were added. After mixing and incubation on ice for 15 min, the tubes were centrifuged to separate the different phases. The RNA-containing upper phase was transferred into a new reaction tube that contained 600 µl isopropanol for RNA precipitation at -20°C overnight. After centrifugation at 10 000 x g for 20 min, the RNA pellet was washed twice with 70% ethanol, dried, and resuspended in 20 µl RNase-free distilled water. The concentration and purity of the RNA were determined photometrically. An aliquot of total RNA (40 ng) was reverse transcribed by 200 U reverse transcriptase using Superscript Preamplification System (Gibco BRL, Karlsruhe, Germany). Twenty microliters of the reaction mixture contained single-strength RT buffer (50 mM Tris-HCl, pH 8.3; 75 mM KCl; 3 mM MgCl2; 0.01% gelatin) and 1 mM dNTP. The reaction was carried out at 22°C for 10 min, followed by a 50-min period at 42°C and a 10-min period at 95°C. One microliter of the resulting cDNA was subsequently amplified with 2.5 U Taq DNA polymerase (Gibco BRL) in 100 µl master mix containing double-strength PCR buffer (10 mM Tris-HCl, pH 7.5; 50 mM KCl; 1.5 mM MgCl2; 0.01% gelatin), 0.25 mM dNTP, and the appropriate primers (50 pmol each). PCR was carried out for 19–34 cycles in an automated thermocycler (Bio-metra, Göttingen, Germany) with the following profile: denaturation at 94°C for 1 min, primer annealing at 50–54°C for 1 min, primer extension at 72°C for 2 min. Ten microliters of resulting samples was brought onto a 1.5% agarose gel; and after electrophoresis in Tris-borate-ETDA buffer, the DNA fragment was stained with ethidium bromide and photographed under UV illumination. The negative film was used for densitometric scanning of the DNA signal.

For each RT-PCR, 40 ng of total RNA was reverse transcribed and the linear part of the amplification curve determined. The resulting cycle numbers were 27 for MMP-1, 25 for MMP-2, 29 for MMP-9, 19 for TIMP-1, and 34 for TIMP-2. For each sample the ribosomal protein L7 was also amplified (24 cycles), and all values are expressed in relation to the housekeeping gene L7.

MMP-1 primers were selected from porcine MMP-1 sequence [29] resulting in a 424-base pair (bp) fragment. The upstream and downstream primers were 5'-TGA TGA AGA TGA AAG GTG-3' and 5'-ATC TCT ATC GGC AAT CTC-3'. MMP-2 primers were based on the mouse and human mRNA sequence [30, 31]. Upstream primer was 5'-ATG ATG GGG AGG CTG ACA-3' and downstream primer was 5'-GGA AGC GGA ACG GAA ACT-3' with a predicted size of 405 bp. Primers for MMP-9 were selected from mouse and bovine MMP-9 mRNA [32, 33] with a predicted size of 452 bp. The sequences of upstream and downstream primer were GGC ACC ACC ACA ACA TCA and GCG GTC GGC GTC GTA GTC. Primers for TIMP-1 were chosen from the human cDNA sequence [34]. The upstream primer was 5'-GCT TCT GGC ATC CTG TTG TTG-3' and downstream primer was 5'-GTC CGT CCA CAA GCA ATG AGT-3' with a predicted size of 492 bp. The upstream and downstream primers for TIMP-2 were synthesized based on the human and bovine cDNA sequence [35, 36] and were 5'-TTA TGG CAA CCC TAT CAA-3' and 5'-ACA GGA GCC GTC ACT TCT-3', respectively. The resulting DNA fragment had a predicted size of 421 bp. The housekeeping gene L7 [37] was determined by the following primers: 5'-AGA TGT ACA GAA CTG AAA TTC-3' and 5'-ATT TAC CAA GAG ATC GAC CAA-3' with a size of 353 bp.

The PCR fragments from MMPs and their inhibitors were cloned into pGEM-4Z vector (Promega, Madison, WI) and sequenced with the A.L.F.-sequencing system (Pharmacia, Freiburg, Germany) to confirm their identity.

Determination of MMP and Progesterone Secretion

MMP-1 release was determined by a "sandwich" ELISA (Amersham, Little Chalfont, England) using specific mouse anti-MMP-1, which did not cross-react with MMP-2 and MMP-9. This assay allows a more sensitive determination of MMP-1 than the zymographic assay. The method of zymography [3, 18] can be used to determine both gelatinases MMP-2 (72 kDa) and MMP-9 (92 kDa). Zymographic analysis was carried out by electrophoresis in 10% (w:v) SDS-polyacrylamide gels impregnated with 0.15% gelatin (w:v). One part of the culture medium was mixed with one part of nonreducing sample buffer (12.5 ml 1 M Tris-HCl, pH 6.8, 4.6 g SDS, 2 ml bromophenol blue, 20 ml glycerol mixed together with distilled water to 100 ml). Ten microliters of sample was applied to the gel, then run with Tris-glycine SDS-running buffer (30 g Tris, 144 g glycine, 10 g SDS to 10 L with distilled water, pH 8.6) at 125 volts until the marker dye reached the bottom of the gel. Thereafter the gel was incubated in renaturing buffer (2.5% Triton X-100 in 100 ml distilled water) for 30 min at room temperature. The renaturing buffer was decanted and replaced with 100 ml developing buffer (50 mM Tris-HCl, pH 7.6, 0.2 M NaCl, 5 mM CaCl2, 0.02% Brij). After equilibration for 30 min with gentle agitation, the buffer was replaced with fresh developing buffer followed by overnight incubation at 37°C. The gel was then stained with Coomassie Blue solution (6.25 g Coomassie Blue, 1.13 L methanol, 230 ml acetic acid with distilled water to 2.5 L) for 10 min followed by incubation (20 min) with destaining solution (1 L methanol, 1.5 L acetic acid with distilled water to 20 L). Quantification of MMP-2 and MMP-9 was achieved by computerized image analysis using two-dimensional scanning densitometry (Scan-Pak; Biometra). Molecular weights of collagenolytic enzymes were determined by comparison with SDS-PAGE molecular weight markers (Bio-Rad Laboratories, Hercules, CA) run in an adjacent lane.

Progesterone secretion by LLC was measured in culture media by a specific, commercial ELISA without extraction (Enzymun-Test, Progesterone; Boehringer-Mannheim, Mannheim, Germany). In brief, 3 µl of culture supernatant was diluted with 300 µl of human hormone-free serum and determined automatically in an ES 700 autoanalyzer (Boehringer-Mannheim). No influence of the culture media on the assay system was found under this condition.

Statistical Analysis

As there were variations from different tissue and cell preparations, the mean values of all tested parameters obtained from tissue or cells collected during the early luteal phase of each experiment were set as 100%, and the other time or treatment points were calculated in relation to this 100% value. This allows calculation of percentage related means and standard errors as well as statistical treatment of these data. To assess the statistical significance of treatment effects, one-way ANOVA was performed, followed by Dunnett's test for multiple comparison (according to the Graph Pad Prism, version 2; Graph Pad Software, San Diego, CA). P < 0.05 was considered significant.


    RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
MMP-1, MMP-2, MMP-9, TIMP-1, and TIMP-2 Gene Expression in Luteal Tissue

Gene expression of the three MMPs and the two TIMPs in luteal tissue obtained at various stages of the estrous cycle is shown in Figure 1. Expression of all three MMP genes increased significantly (P < 0.05) with the age of the CL, while the expression of the TIMP genes showed an inverse pattern with lowest values in tissue of regressing CL (P < 0.05). Expression of the housekeeping gene L-7 did not change significantly.



View larger version (48K):
[in this window]
[in a new window]
 
FIG. 1. Expression of genes encoding MMP-1, MMP-2, and MMP-9, as well as TIMP-1 and TIMP-2, in luteal tissue harvested at different times of the luteal phase. The upper 5 lanes each show 4 examples for PCR products of tissue, obtained during early (left), mid (middle), and late (right) luteal phase. The lower lane shows the unchanged gene expression of the housekeeping gene L7. The graph at the lower part of the figure shows the arbitrary densitometric units of enzyme gene expression. Densitometric units determined during early luteal phase were set at 100%. (*P < 0.05 in comparison to Days 6–8.)

MMP-1, MMP-2, and MMP-9 Secretion by Cultured LLC

The capacity of porcine LLC to secrete MMP-1 into the culture medium was measured by ELISA technique using specific mouse anti-MMP-1, while the simultaneous release of MMP-2 (72 kDa) and MMP-9 (92 kDa) was quantified by gelatin substrate zymography. The latter method allows visualization and quantification of collagenases by their gelatin-degrading activities in conditioned medium of porcine luteal cells (Fig. 2). When the LLC culture medium was serially diluted, the gelatinolytic bands became linearly weaker, indicating the validity of this method. Only a faint band of gelatinolytic activity was observed in unconditioned medium, which was probably due to the presence of 5% FCS.



View larger version (34K):
[in this window]
[in a new window]
 
FIG. 2. A gelatin-containing gel was used for electrophoresis under nondenaturating conditions. After electrophoresis, MMP-2 and MMP-9 digested the gelatin, resulting in bright bands at 72 kDa (MMP-2) and 92 kDa (MMP-9). Serial dilution (U = undiluted; 2, 4, 8 are 1:1, 1:4, and 1:8 dilutions) resulted in progressively less collagenolytic activity. C, Undiluted and unconditioned culture medium that served as control

Immunoreactive MMP-1 (Fig. 3, top) and bioactive MMP-2 and MMP-9 release (Fig. 3, bottom) from LLC increased as a function of age of the CL; i.e., significantly (P < 0.05) higher amounts of immunoreactive MMP-1 and bioactive MMP-2 and MMP-9 were released from cells prepared from aged (regressing) in comparison to young CL. The middle part of Figure 3 shows different zymographic activities in culture media from LLC harvested at different times of the luteal phase.



View larger version (28K):
[in this window]
[in a new window]
 
FIG. 3. In vitro release rates of immunoreactive MMP-1 (top) and of bioactive MMP-2 and MMP-9 (bottom) activities by LLC harvested at Days 6–8, Days 9–11, or during the time of luteolysis (Days 13–15). Representative gelatinolytic bands for MMP-2 and MMP-9 are shown in the middle part of this figure. Mean immunoreactive and bioactive concentrations showed a progressive and significant (*P < 0.05) increase with the age of the CL from which cells were harvested

The release of progesterone by the LLC showed an inverse pattern to MMP secretion (Fig. 4); i.e., progesterone was highest in culture media in which LLC prepared from young CL were cultivated and lowest (P < 0.05) in culture media in which LLC stemming from regressing CL were cultivated.



View larger version (15K):
[in this window]
[in a new window]
 
FIG. 4. Progesterone (P) release of cultured porcine LLC. Basal P release by LLC harvested from CL at the early luteal phase was set 100%. *P < 0.05 vs. P secretion of LLC from the early luteal phase

Figure 5 details the effects of PGF2{alpha} and TNF treatment on progesterone release (top) and on MMP-1, MMP-2, MMP-9, TIMP-1, and TIMP-2 gene expression (bottom) from LLC prepared from CL of the midluteal phase. While both compounds inhibited progesterone release significantly (P < 0.05), they stimulated the expression of the three MMP genes, an effect that was also significant (P < 0.05). In contrast, no up-regulation was observed on TIMP and on L7 gene expression.



View larger version (41K):
[in this window]
[in a new window]
 
FIG. 5. Effects of PGF2{alpha} (10-7 M) and TNF (10-9 M) on progesterone (P) secretion by LLC (top) and on MMP-1, MMP-2, MMP-9, TIMP-1, and TIMP-2 gene expression (bottom). Basal P release and gene expression of these untreated LLC harvested from CL at the midluteal phase were set 100%. *P < 0.05 vs. basal

Figure 6 details the effects of PGF2{alpha} and TNF on MMP-1 release (as determined by ELISA) and on MMP-2 and MMP-9 release (as determined by zymography). Both the prostaglandin and the cytokine stimulated the release of MMP significantly (P < 0.05).



View larger version (20K):
[in this window]
[in a new window]
 
FIG. 6. Effects of PGF2{alpha} (10-7 M) and TNF (10-9 M) on MMP-1, MMP-2, and MMP-9 release by LLC harvested from CL at the midluteal phase. MMP-1 was determined by RIA, while MMP-2 and MMP-9 bioactivities were determined by their gelatinolytic strength (*P < 0.05 vs. basal)

To verify the identity of PCR products, the DNA fragments were cloned and sequenced. The amino acid sequence of the MMP-1 fragment was 100% identical to the predicted porcine MMP-1 protein, while the porcine MMP-2 and MMP-9 fragments were 96% and 92%, respectively, identical to the reported human MMP-2 and mouse MMP-9 amino acid sequences. The protein structure of the porcine TIMP-1 fragment had a 89% homology to the human TIMP-1 amino acid sequence, while the protein sequence of the TIMP-2 DNA fragment was 98% identical to the mouse TIMP-2.


    DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Functional luteolysis includes the participation of several putative luteal and uterine factors. However, very little information is available concerning structural luteolysis. Luteal regression includes extensive tissue remodeling that in many other tissues is associated with increased collagenolytic activities [1, 2, 18, 35, 38]. Previous studies demonstrated that mRNA of the three MMPs and the two TIMPs was expressed in luteal tissue of some species, including the human [911, 14, 16, 18, 39], and that MMP-1 gene expression increased in regressing rat CL [3]. In rat ovarian extracts, this increased gene expression was not associated with increased MMP-1 activity [3], while in the human CL, MMP-2 activity was maximal in the late luteal phase [15].

The present results demonstrate for the first time the gene expression of MMP-1, MMP-2, and MMP-9 as well as of TIMP-1 and TIMP-2 in porcine luteal tissue. While gene expression of all three MMPs increased from the early to the late luteal phase, mRNA levels of TIMP-1 and TIMP-2 decreased continuously to be lowest during the time of luteal regression. These results were corroborated by our cell culture experiments in which an analogous release pattern for MMP-1, MMP-2, and MMP-9 was observed. In contrast to experiments from intact luteal tissue, which contains various cell types, the use of cell cultures allows the demonstration of MMP release from the steroidogenic LLC as well as the release of progesterone as an indicator of functional cell integrity. As shown by gel electrophoresis under nondenaturating conditions followed by zymography, gelatinolytic activity of MMP-2 and MMP-9 was present with the expected molecular masses of 72 kDa and 92 kDa. The MMP-1 release was determined by ELISA technique because the gelatinolytic activity of this MMP is too low to allow the development of a zymographic assay. In contrast to the secretion rates of MMPs, we demonstrated high LLC-progesterone release during the early and midluteal phase that decreased when LLC were prepared from CL of the late luteal phase. The release pattern of the three MMPs supports the hypothesis that increasing amounts of collagenolytic activities may play an important role in structural remodeling that takes place during the regression of the CL. MMP-1 and both gelatinases are also expressed in human CL, in which simultaneous determination of MMP-2 and MMP-9 release by zymography demonstrated increasing secretion rates of gelatinases from the midluteal to the late luteal phase [15]. Unfortunately, there is no sensitive bioassay to measure TIMP activities in the culture medium; reverse zymography [7, 40] proved to be too insensitive. The rate of expression of the TIMP-1 and TIMP-2 genes, however, may indicate that the synthesis rates and possibly also the release rates of both TIMPs are lowest at a time when the CL undergoes structural luteolysis. Although increasing or decreasing expression of genes does not necessarily reflect the translational capacity of cells to synthesize and to posttranslationally process the bioactive product, the parallelism between gene expression of all three MMPs with the release rates of the respective product may indirectly support the conclusion that the reduced expression of the two TIMP genes also indicates less production and release of these two inhibitors. As a net effect of increasing MMP and decreasing TIMP release, the proteolytic activities of the three MMPs would become dominant during luteolysis. In agreement with our findings, previous reports have suggested that TIMP-1 [17] and TIMP-2 [16] gene expression is up-regulated at the early stage of luteal development and that their mRNAs are present in LLC. The physiological function of TIMP-1 and TIMP-2 throughout the life span of CL is unclear at present. There has been discussion that maximal expression of TIMPs during the early luteal phase may be associated with the process of angiogenesis during CL development [16, 17].

There is overwhelming evidence that PGF2{alpha} of uterine origin is necessary to induce luteolysis in the pig [23, 26]. As demonstrated earlier [22] and confirmed in this study, PGF2{alpha} indeed reduces progesterone secretion from porcine LLC. Recently, we demonstrated that the capability of PGF2{alpha} to induce luteolysis is largely enhanced by preexposure of the CL to TNF [26]. In the present experiment we demonstrate again that TNF per se reduces progesterone production. Hence, macrophages that produce large amounts of TNF [25] and that invade the CL at the time of luteolysis [24] appear to be also involved in functional luteolysis. In the present experiment we demonstrate that in cultured LLC, both the eicosanoid and the cytokine also stimulate the gene expression and the secretion of the three studied MMPs, which for the first time demonstrates that both compounds may also be involved in structural luteolysis. It is interesting, however, to note that gene expression of TIMP-1 and TIMP-2 was not significantly altered by PGF2{alpha} or TNF. However, in luteal tissue obtained during the time of luteolysis, TIMP-1 and TIMP-2 gene expression was significantly reduced, indicating that factors other than PGF2{alpha} and TNF may be involved in regulating TIMP-1 and TIMP-2 gene expression.

The present experiments were also performed to analyze which cell type might express the MMP and TIMP genes. Percoll sedimentation and separation techniques did not yield a 100% pure cell population, although the LLC preparation was only slightly contaminated (< 8%) with SLC. Stamouli et al. [39] reported suppressed MMP-2 and MMP-9 in human luteinized granulosa cells, which are the progenitor cells of LLC. Furthermore, Smith et al. found gene expression of both TIMP-1 [17] and TIMP-2 [16] in bovine and ovine LLC, respectively. Since LLC are also estrogen and progesterone receptive [37] and since changes in the gene expression of MMPs and TIMPs occur that vary with the stage of the luteal phase, it is possible that the observed changes in MMP secretion and in the gene expression of MMPs and TIMPs are regulated by the two luteal steroids progesterone and estradiol.

Whether or not steroidogenic SLC also produce MMPs or TIMPs could not be addressed in these experiments because attempts to separate SLC from other nonsteroidogenic cells yielded too high contamination with endothelial cells and lymphocytes.

Outside of the ovary, endothelial cells and cells of the white blood cell line, particularly macrophages, were also shown to produce MMPs and TIMPs [4042]; hence, within the CL, not only the steroidogenic cells but also nonsteroidogenic cells could be a source of these enzymes and their inhibitors.

In summary, we showed increased MMP-1, MMP-2, and MMP-9 and decreased TIMP-1 and TIMP-2 gene expression in regressing porcine CL. LLC harvested from these regressing CL secreted significantly more MMP-1, MMP-2, and MMP-9 in comparison to LLC from young or middle-aged CL. We demonstrated further that the luteolytic substances PGF2{alpha} and TNF stimulated the gene expression and the release of all three MMPs from LLC kept under culture conditions while TIMP gene expression was unaffected by these treatments. The release pattern and gene expression of the three MMPs and their TIMPs allow one to hypothesize that structural remodeling processes that take place during luteolysis are at least in part due to activation of the MMPs and inhibition of the respective TIMPs.


    FOOTNOTES
 
First decision: 1 November 1999.

1 This study was generously funded by the German Research Society (DFG Grant No. Wu 60/10-3). Back

2 Correspondence: L. Pitzel, Division of Clinical and Experimental Endocrinology, Department of Obstetrics and Gynecology, University of Göttingen, Robert-Koch-Strasse 40, D-37075 Göttingen/Germany. FAX: 551 396518; ufkendo{at}med.uni-goettingen.de Back

Accepted: December 1, 1999.

Received: September 23, 1999.


    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Woessner JF Jr. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 1991; 5:2145–2154.[Abstract]
  2. Espey LL. Ovulation as an inflammatory reaction—a hypothesis. Biol Reprod 1980; 22:73–106.[CrossRef][Medline]
  3. Nothnick WB, Keeble SC, Curry TE Jr. Collagenase, gelatinase, and proteoglycanase messenger ribonucleic acid expression and activity during luteal development, maintenance, and regression in the pseudopregnant rat ovary. Biol Reprod 1996; 54:616–624.[Abstract]
  4. Tsafriri A, Chun SY, Reich R. Follicular rupture and ovulation. In: Adashi EY, Leung PK (eds.), The Ovary. New York: Raven Press; 1993: 227–244.
  5. Chun SY, Reich R, Spiess S, Pitzel L, Wuttke W, Tsafriri A. Localization of interstitial collagenase gene expression in gilt preovulatory follicles. Endocr J 1993; 1:481–486.
  6. Hirsch B, Leonhardt S, Jarry H, Reich R, Tsafriri A, Wuttke W. In vivo measurement of rat ovarian collagenolytic activities. Endocrinology 1993; 133:2761–2765.[Abstract]
  7. Salamonsen LA. Matrix metalloproteinases and their tissue inhibitors in endocrinology. TEM 1996; 7:28–34.
  8. Sottrup-Jensen L, Birkedal-Hansen H. Human fibroblast collagenase-{alpha}-macroglobulin interactions. J Biol Chem 1989; 264:393–401.[Abstract/Free Full Text]
  9. Juengel JL, Smith GW, Smith MF, Youngquist RS, Garverick HA. Pattern of protein production by bovine corpora lutea during luteolysis and characterization of expression of two major secretory products of the regressing corpora lutea. J Reprod Fertil 1994; 100:513–520.
  10. Smith GW, Goetz TL, Anthony RV, Smith MF. Molecular cloning of an ovine ovarian tissue inhibitor of metalloproteinases: ontogeny of messenger ribonucleic acid expression and in situ localization within preovulatory follicles and luteal tissue. Endocrinology 1994; 134:344–352.[Abstract]
  11. Smith MF, Kemper CN, Smith GW, Goetz TL, Jarell VL. Production of tissue inhibitor of metalloproteinase-1 by porcine follicular and luteal cells. J Anim Sci 1994; 72:1004–1012.[Abstract]
  12. Mann JS, Kindy MS, Edwards DR, Curry TE Jr. Hormonal regulation of matrix metalloproteinase inhibitors in rat granulosa cells and ovaries. Endocrinology 1991; 128:1825–1832.[Abstract]
  13. Nothnick WB, Edwards DR, Leco KJ, Curry TE Jr. Expression and activity of ovarian tissue inhibitors of metalloproteinases during pseudopregnancy in the rat. Biol Reprod 1995; 53:684–691.[Abstract]
  14. Tsang PCW, Poff JP, Boulton EP, Condon WA. Four-day-old bovine corpus luteum: progesterone production and identification of matrix metalloproteinase activity in vitro. Biol Reprod 1995; 53:1160–1168.[Abstract]
  15. Duncan WC, McNeilly AS, Illingworth PJ. The effect of luteal "rescue" on the expression and localization of matrix metalloproteinases and their tissue inhibitors in the human corpus luteum. Endocrinology 1998; 83:2470–2478.
  16. Smith GW, McCrone S, Petersen SL, Smith MF. Expression of messenger ribonucleic acid encoding tissue inhibitor of metalloproteinase-2 within ovine follicles and corpora lutea. Endocrinology 1995; 136:570–576.[Abstract]
  17. Smith GW, Juengel JL, McIntush EW, Youngquist RS, Garverick HA, Smith MF. Ontogenies of messenger RNA encoding tissue inhibitor of metalloproteinases 1 and 2 within bovine periovulatory follicles and luteal tissue. Domest Anim Endocrinol 1996; 13:151–160.[CrossRef][Medline]
  18. Curry TE Jr, Mann JS, Huang MH, Keeble SC. Gelatinase and proteoglycanase activity during the preovulatory period in the rat. Biol Reprod 1992; 46:256–264.[Abstract]
  19. Lemon M, Loir M. Steroid release in vitro by two luteal cell types in the corpus luteum of the pregnant sow. J Endocrinol 1977; 72:351–357.[Abstract]
  20. Rodgers RJ, O'Shea JD. Purification, morphology, and progesterone production and content of three cell types isolated from the corpus luteum of the sheep. Aust J Biol Sci 1982; 35:441–455.[Medline]
  21. Hoyer PB, Niswender GD. The regulation of steroidogenesis is different in the two types of ovine luteal cells. Can J Physiol Pharmacol 1985; 63:240–248.[Medline]
  22. Pitzel L, Jarry H, Wuttke W. Effects and interactions of prostaglandin F2{alpha}, oxytocin, and cytokines on steroidogenesis of porcine luteal cells. Endocrinology 1993; 132:751–756.[Abstract]
  23. Moeljono MPE, Bazer FW, Thatcher WW. A study of prostaglandin F2{alpha} as the luteolysin in swine: I. Effect of prostaglandin F2{alpha} in hysterectomized gilts. Prostaglandins 1976; 11:737–743.[CrossRef][Medline]
  24. Hehnke KE, Christenson LK, Ford SP, Taylor M. Macrophage infiltration into the porcine corpus luteum during prostaglandin F2{alpha}-induced luteolysis. Biol Reprod 1994; 50:10–15.[Abstract]
  25. Wuttke W, Pitzel L, Knoke I, Theiling K, Jarry H. Immune-endocrine interactions affecting luteal function in pigs. J Reprod Fertil Suppl 1997; 52:19–29.[Medline]
  26. Wuttke W, Spiess S, Knoke I, Pitzel L, Leonhardt S, Jarry H. Synergistic effects of prostaglandin F2{alpha} and tumor necrosis factor to induce luteolysis in the pig. Biol Reprod 1998; 58:1310–1315.[Abstract/Free Full Text]
  27. Pitzel L, Jarry H, Wuttke W. Effects of oxytocin on in vitro steroid release of midstage small and large porcine luteal cells. Endocrinology 1990; 126:2343–2349.[Abstract]
  28. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162:156–159.[Medline]
  29. Clarke NJ, O'Hare MC, Cawston TE, Harper GP. Nucleotide sequence of a cDNA for porcine type I collagenase, obtained by PCR. Nucleic Acids Res 1990; 18:6703–6707.[Free Full Text]
  30. Collier IE, Wilhelm SM, Eisen AZ, Marmer BL, Grant GA, Seltzer JL, Kronberger A, He C, Bauer EA, Goldberg GI. H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloproteinase capable of degrading basement membrane collagen. J Biol Chem 1988; 263:6579–6587.[Abstract/Free Full Text]
  31. Reponen P, Sahlberg C, Huhtala P, Hurskainen T, Thesleff I, Tryggvason K. Molecular cloning of 72-kDa type IV collagenase and its expressing during mouse development. J Biol Chem 1992; 267:7856–7862.[Abstract/Free Full Text]
  32. Reponen P, Sahlberg C, Munant C, Thesleff I, Tryggvason K. High expression of 92 kDa type IV collagenase (gelatinase B) in the osteoclast lineage during mouse development. J Cell Biol 1994; 124:1091–1102.[Abstract/Free Full Text]
  33. Baylis HA, Meyson A, Hall R. Infection with theileria annulata induces expression of matrix metalloproteinase 9 and transcription factor AP-1 in bovine leucocytes. Mol Biochem Parasitol 1995; 69:211–222.[CrossRef][Medline]
  34. Carmichael DF, Sommer A, Tompson RC, Anderson DC, Smith CG, Welgus HG, Stricklin GP. Primary structure and cDNA cloning of human fibroblast collagenase inhibitor. Proc Natl Acad Sci USA 1986; 83:2407–2411.[Abstract/Free Full Text]
  35. Stetler-Stevenson WG, Brown PD, Onisto M, Levy AT, Liotta LA. Tissue inhibitor of metalloproteinases-2 (TIMP-2) mRNA expression in tumor cell lines and human tumor tissues. J Biol Chem 1990; 265:13933–13938.[Abstract/Free Full Text]
  36. Boone TC, Johnson MJ, de Clerck YA, Langley KE. cDNA cloning and expression of a metalloproteinase inhibitor related to tissue inhibitor of metalloproteinases. Proc Natl Acad Sci USA 1990; 87:2800–2804.[Abstract/Free Full Text]
  37. Theiling K, Jarry H, Pitzel L, Wuttke W. Estrogen and progesterone receptor gene expression in the porcine and human corpus luteum in relation to the stage of the luteal phase. Exp Clin Endocrinol Diabetes 1997; 105(suppl 1):82.
  38. Alexander CM, Werb Z. Proteinases and extracellular matrix remodeling. Curr Opin Cell Biol 1989; 1:974–982.[CrossRef][Medline]
  39. Stamouli A, O'Sullivan MJB, Frankel S, Thomas EJ, Richardson MC. Suppression of matrix metalloproteinase production by hCG in cultures of human luteinized granulosa cells as a model for gonadotrophin-induced luteal rescue. J Reprod Fertil 1996; 105:235–239.
  40. Kishani NS, Staskus PW, Yang T-T, Masiarz FR, Hawkes SP. Identification and characterization of human tissue inhibitor of metalloproteinases and detection of three additional metalloproteinase inhibitor activities in extracellular matrix. Matrix Biol 1994: 14:479–488.
  41. Hanemaaijer R, Koolwijk P, LeClercq L, DeVree WJA, Van Hinsberg VWM. Regulation of matrix metalloproteinase expression in human vein and microvascular endothelial cells. Biochem J 1993; 296:803–809.
  42. Galis ZS, Sukhova GK, Kranzhöfer K, Clark S, Libby P. Macrophage cells from experimental atheroma constitutively produce matrix-degrading proteinases. Proc Natl Acad Sci USA 1995; 92:402–406.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
EndocrinologyHome page
M. Myers, M. C. Lamont, S. van den Driesche, N. Mary, K. J. Thong, S. G. Hillier, and W. C. Duncan
Role of Luteal Glucocorticoid Metabolism during Maternal Recognition of Pregnancy in Women
Endocrinology, December 1, 2007; 148(12): 5769 - 5779.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. Myers, E. Gay, A. S. McNeilly, H. M. Fraser, and W. C. Duncan
In Vitro Evidence Suggests Activin-A May Promote Tissue Remodeling Associated with Human Luteolysis
Endocrinology, August 1, 2007; 148(8): 3730 - 3739.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
K. A. Young and R. L. Stouffer
Gonadotropin and Steroid Regulation of Matrix Metalloproteinases and Their Endogenous Tissue Inhibitors in the Developed Corpus Luteum of the Rhesus Monkey During the Menstrual Cycle
Biol Reprod, January 1, 2004; 70(1): 244 - 252.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
T. E. Curry Jr. and K. G. Osteen
The Matrix Metalloproteinase System: Changes, Regulation, and Impact throughout the Ovarian and Uterine Reproductive Cycle
Endocr. Rev., August 1, 2003; 24(4): 428 - 465.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
T. E. Curry Jr and S. E. Wheeler
Cellular Localization of Tissue Inhibitors of Metalloproteinases in the Rat Ovary Throughout Pseudopregnancy
Biol Reprod, December 1, 2002; 67(6): 1943 - 1951.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
K.A. Young, J.D. Hennebold, and R.L. Stouffer
Dynamic expression of mRNAs and proteins for matrix metalloproteinases and their tissue inhibitors in the primate corpus luteum during the menstrual cycle
Mol. Hum. Reprod., September 1, 2002; 8(9): 833 - 840.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
B. Zhang, L. Yan, M. A. Moses, and P. C.W. Tsang
Bovine Membrane-Type 1 Matrix Metalloproteinase: Molecular Cloning and Expression in the Corpus Luteum
Biol Reprod, July 1, 2002; 67(1): 99 - 106.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
T. A. Towle, P. C.W. Tsang, R. A. Milvae, M. K. Newbury, and J. A. McCracken
Dynamic In Vivo Changes in Tissue Inhibitors of Metalloproteinases 1 and 2, and Matrix Metalloproteinases 2 and 9, During Prostaglandin F2{alpha}-Induced Luteolysis in Sheep
Biol Reprod, May 1, 2002; 66(5): 1515 - 1521.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
J. A. Lenhart, P. L. Ryan, K. M. Ohleth, S. S. Palmer, and C. A. Bagnell
Relaxin Increases Secretion of Tissue Inhibitor of Matrix Metalloproteinase-1 and -2 during Uterine and Cervical Growth and Remodeling in the Pig
Endocrinology, January 1, 2002; 143(1): 91 - 98.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
E. Shalev, S. Goldman, and I. Ben-Shlomo
The balance between MMP-9 and MMP-2 and their tissue inhibitor (TIMP)-1 in luteinized granulosa cells: comparison between women with PCOS and normal ovulatory women
Mol. Hum. Reprod., April 1, 2001; 7(4): 325 - 331.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pitzel, L.
Right arrow Articles by Wuttke, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pitzel, L.
Right arrow Articles by Wuttke, W.
Agricola
Right arrow Articles by Pitzel, L.
Right arrow Articles by Wuttke, W.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS